These activatable probes will support downstream activity‐based protein profiling and enable noninvasive imaging of the enzyme activity, offering a powerful means for dissecting the multifaceted biology of GzmA within the tumor immune microenvironment. The gene discussed is GZMA; the disease is neoplasm.